Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dr. Charlotte van den Bosch, neuroloog from Malle, company number BE0793476727, closed financial year 2025 with a result of € 47,702 after tax. For that financial year Dr. Charlotte van den Bosch, neuroloog recorded a gross margin of € 61,000 and equity of € 141,785. Compared with financial year 2024, the result moved from € 28,777 to € 47,702. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 141,785
▲ 51% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 47,702
▲ 66% vs 2024
Profit after tax over the fiscal year.
€ 7,026
▲ 45% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 139,785.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 964
Loans from banks and other lenders, long and short.
€ 1,983
▼ 93% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 22,707
▲ 49% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 79,777 | € 37,522 | € 61,000 | ▲ 63% |
| Profit after taxes | € 63,306 | € 28,777 | € 47,702 | ▲ 66% |
| Equity | € 65,306 | € 94,083 | € 141,785 | ▲ 51% |
| Total debts | € 24,545 | € 42,943 | € 25,654 | ▼ 40% |
| Cash | € 24,359 | € 4,842 | € 7,026 | ▲ 45% |
| Retained profit | € 63,306 | € 92,083 | € 139,785 | ▲ 52% |
| Bank debt | € 0 | € 0 | € 964 | |
| Balance sheet total | € 89,851 | € 137,026 | € 167,439 | ▲ 22% |
Key figures of Dr. Charlotte van den Bosch, neuroloog, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Charlotte van den Bosch, neuroloog?
What happened at Dr. Charlotte van den Bosch, neuroloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 47,702 (▲ 66% vs 2024). filed late Source: NBB ↗
- New establishment in Malle. KBO
- Charlotte van den Bosch became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 63,306 profit in 2023 to € 47,702 profit in 2025.
Paid € 35,208 in corporate taxes since 2023.
Best year ever: 2023, with € 63,306 profit.
A new publication or filing at Dr. Charlotte van den Bosch, neuroloog? We notify you, reason included.
Follow Dr. Charlotte van den Bosch, neuroloogDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Charlotte van den Bosch, neuroloog is Charlotte van den Bosch.
Directors
According to the 2025 annual accounts
Charlotte van den Bosch
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Antwerpsesteenweg 338A box 5
2390 Malle
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →GIGANT
€ 934,788 gross margin · 2024
Jumbo
€ 101,668 gross margin · 2024
KRYPTON
€ -1,655 gross margin · 2024
NEPTUNUS
€ 87,323 gross margin · 2023
ROELS
€ 73,014 gross margin · 2024
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0793.476.727
- VAT number
- BE 0793.476.727
- Registered office
- Antwerpsesteenweg 338A bus 5, 2390 Malle
- Names & denominations
- Dr. Charlotte van den Bosch, neuroloog
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 November 2022
- Peppol
- Not registered